nodes	percent_of_prediction	percent_of_DWPC	metapath
Tenofovir—ABCC10—Docetaxel—skin cancer	0.231	0.315	CbGbCtD
Tenofovir—ABCC4—Fluorouracil—skin cancer	0.145	0.198	CbGbCtD
Tenofovir—CYP1A2—Imiquimod—skin cancer	0.131	0.179	CbGbCtD
Tenofovir—CYP1A2—Vemurafenib—skin cancer	0.0717	0.098	CbGbCtD
Tenofovir—ABCC2—Docetaxel—skin cancer	0.066	0.0902	CbGbCtD
Tenofovir—CYP1A2—Dacarbazine—skin cancer	0.0549	0.0751	CbGbCtD
Tenofovir—CYP1A2—Fluorouracil—skin cancer	0.0322	0.044	CbGbCtD
Tenofovir—NME1—neck—skin cancer	0.00522	0.0672	CbGeAlD
Tenofovir—AK4—nipple—skin cancer	0.00508	0.0654	CbGeAlD
Tenofovir—NME1-NME2—female reproductive system—skin cancer	0.00453	0.0584	CbGeAlD
Tenofovir—AK2—mammalian vulva—skin cancer	0.00401	0.0516	CbGeAlD
Tenofovir—NME1-NME2—head—skin cancer	0.00379	0.0487	CbGeAlD
Tenofovir—NME1—connective tissue—skin cancer	0.00374	0.0481	CbGeAlD
Tenofovir—NME1—skin of body—skin cancer	0.00338	0.0435	CbGeAlD
Tenofovir—NME2—epithelium—skin cancer	0.00334	0.043	CbGeAlD
Tenofovir—AK4—mammalian vulva—skin cancer	0.00297	0.0382	CbGeAlD
Tenofovir—NME1—lymphoid tissue—skin cancer	0.00273	0.0352	CbGeAlD
Tenofovir—NME1-NME2—lymph node—skin cancer	0.00265	0.0341	CbGeAlD
Tenofovir—NME1—female reproductive system—skin cancer	0.00264	0.0339	CbGeAlD
Tenofovir—NME2—lymphoid tissue—skin cancer	0.00257	0.0331	CbGeAlD
Tenofovir—AK4—female reproductive system—skin cancer	0.00254	0.0327	CbGeAlD
Tenofovir—NME2—female reproductive system—skin cancer	0.00248	0.032	CbGeAlD
Tenofovir—ABCC10—nipple—skin cancer	0.00241	0.031	CbGeAlD
Tenofovir—NME1—head—skin cancer	0.0022	0.0284	CbGeAlD
Tenofovir—AK4—head—skin cancer	0.00212	0.0273	CbGeAlD
Tenofovir—NME2—head—skin cancer	0.00207	0.0267	CbGeAlD
Tenofovir—AK2—lymph node—skin cancer	0.00201	0.0259	CbGeAlD
Tenofovir—NME1—lymph node—skin cancer	0.00154	0.0199	CbGeAlD
Tenofovir—Infestation NOS—Vemurafenib—skin cancer	0.00151	0.00794	CcSEcCtD
Tenofovir—Infestation—Vemurafenib—skin cancer	0.00151	0.00794	CcSEcCtD
Tenofovir—AK4—lymph node—skin cancer	0.00149	0.0191	CbGeAlD
Tenofovir—Neuropathy peripheral—Vemurafenib—skin cancer	0.00148	0.00778	CcSEcCtD
Tenofovir—NME2—lymph node—skin cancer	0.00145	0.0187	CbGeAlD
Tenofovir—Musculoskeletal discomfort—Vismodegib—skin cancer	0.00142	0.00747	CcSEcCtD
Tenofovir—ABCC10—mammalian vulva—skin cancer	0.00141	0.0181	CbGeAlD
Tenofovir—Dyspepsia—Vismodegib—skin cancer	0.00138	0.00721	CcSEcCtD
Tenofovir—Decreased appetite—Vismodegib—skin cancer	0.00136	0.00712	CcSEcCtD
Tenofovir—CYP1A2—nipple—skin cancer	0.00136	0.0175	CbGeAlD
Tenofovir—Gastrointestinal disorder—Vismodegib—skin cancer	0.00135	0.00708	CcSEcCtD
Tenofovir—Fatigue—Vismodegib—skin cancer	0.00135	0.00707	CcSEcCtD
Tenofovir—Upper respiratory tract infection—Imiquimod—skin cancer	0.00135	0.00706	CcSEcCtD
Tenofovir—Pain—Vismodegib—skin cancer	0.00134	0.00701	CcSEcCtD
Tenofovir—Connective tissue disorder—Vemurafenib—skin cancer	0.00134	0.007	CcSEcCtD
Tenofovir—Infestation—Imiquimod—skin cancer	0.00129	0.00677	CcSEcCtD
Tenofovir—Infestation NOS—Imiquimod—skin cancer	0.00129	0.00677	CcSEcCtD
Tenofovir—Depression—Imiquimod—skin cancer	0.00129	0.00675	CcSEcCtD
Tenofovir—Gastrointestinal pain—Vismodegib—skin cancer	0.00128	0.0067	CcSEcCtD
Tenofovir—Neuropathy peripheral—Imiquimod—skin cancer	0.00127	0.00664	CcSEcCtD
Tenofovir—ABCC10—lymphoid tissue—skin cancer	0.00125	0.0161	CbGeAlD
Tenofovir—Abdominal pain—Vismodegib—skin cancer	0.00124	0.00648	CcSEcCtD
Tenofovir—Mediastinal disorder—Vemurafenib—skin cancer	0.00122	0.00642	CcSEcCtD
Tenofovir—Hepatobiliary disease—Imiquimod—skin cancer	0.00122	0.0064	CcSEcCtD
Tenofovir—Sinusitis—Imiquimod—skin cancer	0.00121	0.00635	CcSEcCtD
Tenofovir—ABCC10—female reproductive system—skin cancer	0.00121	0.0155	CbGeAlD
Tenofovir—Malnutrition—Vemurafenib—skin cancer	0.00118	0.0062	CcSEcCtD
Tenofovir—Urinary tract disorder—Imiquimod—skin cancer	0.00114	0.006	CcSEcCtD
Tenofovir—Back pain—Vemurafenib—skin cancer	0.00114	0.006	CcSEcCtD
Tenofovir—Connective tissue disorder—Imiquimod—skin cancer	0.00114	0.00597	CcSEcCtD
Tenofovir—Urethral disorder—Imiquimod—skin cancer	0.00114	0.00596	CcSEcCtD
Tenofovir—Asthenia—Vismodegib—skin cancer	0.00112	0.00588	CcSEcCtD
Tenofovir—Pruritus—Vismodegib—skin cancer	0.00111	0.0058	CcSEcCtD
Tenofovir—Diarrhoea—Vismodegib—skin cancer	0.00107	0.00561	CcSEcCtD
Tenofovir—Immune system disorder—Imiquimod—skin cancer	0.00105	0.00549	CcSEcCtD
Tenofovir—Mediastinal disorder—Imiquimod—skin cancer	0.00104	0.00548	CcSEcCtD
Tenofovir—Mental disorder—Imiquimod—skin cancer	0.00102	0.00532	CcSEcCtD
Tenofovir—Malnutrition—Imiquimod—skin cancer	0.00101	0.00529	CcSEcCtD
Tenofovir—Myalgia—Vemurafenib—skin cancer	0.00101	0.00528	CcSEcCtD
Tenofovir—Arthralgia—Vemurafenib—skin cancer	0.00101	0.00528	CcSEcCtD
Tenofovir—Unspecified disorder of skin and subcutaneous tissue—Vemurafenib—skin cancer	0.001	0.00525	CcSEcCtD
Tenofovir—ABCC4—female reproductive system—skin cancer	0.001	0.0129	CbGeAlD
Tenofovir—Vomiting—Vismodegib—skin cancer	0.000994	0.00521	CcSEcCtD
Tenofovir—Rash—Vismodegib—skin cancer	0.000985	0.00517	CcSEcCtD
Tenofovir—Dermatitis—Vismodegib—skin cancer	0.000985	0.00516	CcSEcCtD
Tenofovir—Back pain—Imiquimod—skin cancer	0.000976	0.00512	CcSEcCtD
Tenofovir—ABCC2—female reproductive system—skin cancer	0.000968	0.0125	CbGeAlD
Tenofovir—Bone pain—Docetaxel—skin cancer	0.00096	0.00504	CcSEcCtD
Tenofovir—Nervous system disorder—Vemurafenib—skin cancer	0.000947	0.00497	CcSEcCtD
Tenofovir—Skin disorder—Vemurafenib—skin cancer	0.000938	0.00492	CcSEcCtD
Tenofovir—Weight decreased—Bleomycin—skin cancer	0.000931	0.00488	CcSEcCtD
Tenofovir—Nausea—Vismodegib—skin cancer	0.000928	0.00487	CcSEcCtD
Tenofovir—Pneumonia—Bleomycin—skin cancer	0.000923	0.00484	CcSEcCtD
Tenofovir—Angioedema—Imiquimod—skin cancer	0.000922	0.00483	CcSEcCtD
Tenofovir—Hypokalaemia—Temozolomide—skin cancer	0.000914	0.00479	CcSEcCtD
Tenofovir—Muscular weakness—Temozolomide—skin cancer	0.000885	0.00464	CcSEcCtD
Tenofovir—Musculoskeletal discomfort—Vemurafenib—skin cancer	0.00088	0.00461	CcSEcCtD
Tenofovir—Haematuria—Bleomycin—skin cancer	0.000875	0.00459	CcSEcCtD
Tenofovir—Pneumonia—Dactinomycin—skin cancer	0.00086	0.00451	CcSEcCtD
Tenofovir—Myalgia—Imiquimod—skin cancer	0.000859	0.0045	CcSEcCtD
Tenofovir—Chest pain—Imiquimod—skin cancer	0.000859	0.0045	CcSEcCtD
Tenofovir—Arthralgia—Imiquimod—skin cancer	0.000859	0.0045	CcSEcCtD
Tenofovir—Anxiety—Imiquimod—skin cancer	0.000856	0.00449	CcSEcCtD
Tenofovir—Unspecified disorder of skin and subcutaneous tissue—Imiquimod—skin cancer	0.000853	0.00447	CcSEcCtD
Tenofovir—Decreased appetite—Vemurafenib—skin cancer	0.000839	0.0044	CcSEcCtD
Tenofovir—ABCC4—head—skin cancer	0.000835	0.0108	CbGeAlD
Tenofovir—Gastrointestinal disorder—Vemurafenib—skin cancer	0.000834	0.00437	CcSEcCtD
Tenofovir—Fatigue—Vemurafenib—skin cancer	0.000832	0.00437	CcSEcCtD
Tenofovir—SLC22A8—head—skin cancer	0.000829	0.0107	CbGeAlD
Tenofovir—Nasopharyngitis—Fluorouracil—skin cancer	0.000827	0.00434	CcSEcCtD
Tenofovir—Muscular weakness—Fluorouracil—skin cancer	0.000816	0.00428	CcSEcCtD
Tenofovir—Nervous system disorder—Imiquimod—skin cancer	0.000808	0.00423	CcSEcCtD
Tenofovir—Upper respiratory tract infection—Temozolomide—skin cancer	0.000806	0.00423	CcSEcCtD
Tenofovir—Skin disorder—Imiquimod—skin cancer	0.0008	0.00419	CcSEcCtD
Tenofovir—Hyperhidrosis—Imiquimod—skin cancer	0.000796	0.00417	CcSEcCtD
Tenofovir—Weight decreased—Temozolomide—skin cancer	0.000785	0.00412	CcSEcCtD
Tenofovir—Anorexia—Imiquimod—skin cancer	0.000785	0.00412	CcSEcCtD
Tenofovir—Hyperglycaemia—Temozolomide—skin cancer	0.000783	0.0041	CcSEcCtD
Tenofovir—Pneumonia—Temozolomide—skin cancer	0.000778	0.00408	CcSEcCtD
Tenofovir—Infestation NOS—Temozolomide—skin cancer	0.000774	0.00406	CcSEcCtD
Tenofovir—Infestation—Temozolomide—skin cancer	0.000774	0.00406	CcSEcCtD
Tenofovir—Depression—Temozolomide—skin cancer	0.000771	0.00405	CcSEcCtD
Tenofovir—Hepatitis—Dactinomycin—skin cancer	0.000768	0.00403	CcSEcCtD
Tenofovir—Body temperature increased—Vemurafenib—skin cancer	0.000763	0.004	CcSEcCtD
Tenofovir—Neuropathy peripheral—Temozolomide—skin cancer	0.000758	0.00398	CcSEcCtD
Tenofovir—Musculoskeletal discomfort—Imiquimod—skin cancer	0.00075	0.00393	CcSEcCtD
Tenofovir—Insomnia—Imiquimod—skin cancer	0.000745	0.00391	CcSEcCtD
Tenofovir—Upper respiratory tract infection—Fluorouracil—skin cancer	0.000743	0.0039	CcSEcCtD
Tenofovir—Dyspnoea—Imiquimod—skin cancer	0.000734	0.00385	CcSEcCtD
Tenofovir—Hepatobiliary disease—Temozolomide—skin cancer	0.000732	0.00384	CcSEcCtD
Tenofovir—Sinusitis—Temozolomide—skin cancer	0.000726	0.00381	CcSEcCtD
Tenofovir—Dyspepsia—Imiquimod—skin cancer	0.000725	0.0038	CcSEcCtD
Tenofovir—Pneumonia—Fluorouracil—skin cancer	0.000717	0.00376	CcSEcCtD
Tenofovir—Decreased appetite—Imiquimod—skin cancer	0.000716	0.00375	CcSEcCtD
Tenofovir—Infestation NOS—Fluorouracil—skin cancer	0.000713	0.00374	CcSEcCtD
Tenofovir—Infestation—Fluorouracil—skin cancer	0.000713	0.00374	CcSEcCtD
Tenofovir—Hypersensitivity—Vemurafenib—skin cancer	0.000711	0.00373	CcSEcCtD
Tenofovir—Gastrointestinal disorder—Imiquimod—skin cancer	0.000711	0.00373	CcSEcCtD
Tenofovir—Fatigue—Imiquimod—skin cancer	0.00071	0.00372	CcSEcCtD
Tenofovir—ABCC10—lymph node—skin cancer	0.000705	0.00908	CbGeAlD
Tenofovir—Pain—Imiquimod—skin cancer	0.000704	0.00369	CcSEcCtD
Tenofovir—Renal impairment—Docetaxel—skin cancer	0.000702	0.00368	CcSEcCtD
Tenofovir—Neuropathy peripheral—Fluorouracil—skin cancer	0.000699	0.00366	CcSEcCtD
Tenofovir—Hepatitis—Temozolomide—skin cancer	0.000695	0.00364	CcSEcCtD
Tenofovir—Asthenia—Vemurafenib—skin cancer	0.000693	0.00363	CcSEcCtD
Tenofovir—Urinary tract disorder—Temozolomide—skin cancer	0.000686	0.0036	CcSEcCtD
Tenofovir—Pruritus—Vemurafenib—skin cancer	0.000683	0.00358	CcSEcCtD
Tenofovir—Connective tissue disorder—Temozolomide—skin cancer	0.000683	0.00358	CcSEcCtD
Tenofovir—Urethral disorder—Temozolomide—skin cancer	0.000681	0.00357	CcSEcCtD
Tenofovir—Gastrointestinal pain—Imiquimod—skin cancer	0.000673	0.00353	CcSEcCtD
Tenofovir—Sinusitis—Fluorouracil—skin cancer	0.000669	0.00351	CcSEcCtD
Tenofovir—Diarrhoea—Vemurafenib—skin cancer	0.000661	0.00346	CcSEcCtD
Tenofovir—Abdominal pain—Imiquimod—skin cancer	0.000651	0.00341	CcSEcCtD
Tenofovir—Body temperature increased—Imiquimod—skin cancer	0.000651	0.00341	CcSEcCtD
Tenofovir—Dizziness—Vemurafenib—skin cancer	0.000638	0.00335	CcSEcCtD
Tenofovir—Immune system disorder—Temozolomide—skin cancer	0.000627	0.00329	CcSEcCtD
Tenofovir—Mediastinal disorder—Temozolomide—skin cancer	0.000626	0.00328	CcSEcCtD
Tenofovir—Vomiting—Vemurafenib—skin cancer	0.000614	0.00322	CcSEcCtD
Tenofovir—Myalgia—Bleomycin—skin cancer	0.00061	0.0032	CcSEcCtD
Tenofovir—Chest pain—Bleomycin—skin cancer	0.00061	0.0032	CcSEcCtD
Tenofovir—Rash—Vemurafenib—skin cancer	0.000609	0.00319	CcSEcCtD
Tenofovir—Mental disorder—Temozolomide—skin cancer	0.000609	0.00319	CcSEcCtD
Tenofovir—Dermatitis—Vemurafenib—skin cancer	0.000608	0.00319	CcSEcCtD
Tenofovir—Hypersensitivity—Imiquimod—skin cancer	0.000607	0.00318	CcSEcCtD
Tenofovir—Headache—Vemurafenib—skin cancer	0.000605	0.00317	CcSEcCtD
Tenofovir—Malnutrition—Temozolomide—skin cancer	0.000605	0.00317	CcSEcCtD
Tenofovir—Nasopharyngitis—Docetaxel—skin cancer	0.000597	0.00313	CcSEcCtD
Tenofovir—Asthenia—Imiquimod—skin cancer	0.000591	0.0031	CcSEcCtD
Tenofovir—ABCC4—lymph node—skin cancer	0.000585	0.00753	CbGeAlD
Tenofovir—Back pain—Temozolomide—skin cancer	0.000585	0.00307	CcSEcCtD
Tenofovir—Pruritus—Imiquimod—skin cancer	0.000583	0.00306	CcSEcCtD
Tenofovir—Nausea—Vemurafenib—skin cancer	0.000574	0.00301	CcSEcCtD
Tenofovir—Myalgia—Dactinomycin—skin cancer	0.000569	0.00298	CcSEcCtD
Tenofovir—ABCC2—lymph node—skin cancer	0.000566	0.00729	CbGeAlD
Tenofovir—Diarrhoea—Imiquimod—skin cancer	0.000563	0.00295	CcSEcCtD
Tenofovir—Anorexia—Bleomycin—skin cancer	0.000558	0.00292	CcSEcCtD
Tenofovir—Angioedema—Temozolomide—skin cancer	0.000552	0.0029	CcSEcCtD
Tenofovir—Dizziness—Imiquimod—skin cancer	0.000545	0.00286	CcSEcCtD
Tenofovir—Musculoskeletal discomfort—Bleomycin—skin cancer	0.000533	0.00279	CcSEcCtD
Tenofovir—Vomiting—Imiquimod—skin cancer	0.000524	0.00275	CcSEcCtD
Tenofovir—Weight decreased—Docetaxel—skin cancer	0.000522	0.00274	CcSEcCtD
Tenofovir—Dyspnoea—Bleomycin—skin cancer	0.000522	0.00274	CcSEcCtD
Tenofovir—Anorexia—Dactinomycin—skin cancer	0.00052	0.00273	CcSEcCtD
Tenofovir—Rash—Imiquimod—skin cancer	0.000519	0.00272	CcSEcCtD
Tenofovir—Dermatitis—Imiquimod—skin cancer	0.000519	0.00272	CcSEcCtD
Tenofovir—Pneumonia—Docetaxel—skin cancer	0.000518	0.00271	CcSEcCtD
Tenofovir—Headache—Imiquimod—skin cancer	0.000516	0.00271	CcSEcCtD
Tenofovir—Myalgia—Temozolomide—skin cancer	0.000515	0.0027	CcSEcCtD
Tenofovir—Arthralgia—Temozolomide—skin cancer	0.000515	0.0027	CcSEcCtD
Tenofovir—Infestation—Docetaxel—skin cancer	0.000515	0.0027	CcSEcCtD
Tenofovir—Infestation NOS—Docetaxel—skin cancer	0.000515	0.0027	CcSEcCtD
Tenofovir—Anxiety—Temozolomide—skin cancer	0.000513	0.00269	CcSEcCtD
Tenofovir—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—skin cancer	0.000511	0.00268	CcSEcCtD
Tenofovir—Decreased appetite—Bleomycin—skin cancer	0.000509	0.00267	CcSEcCtD
Tenofovir—Renal failure—Docetaxel—skin cancer	0.000506	0.00265	CcSEcCtD
Tenofovir—Neuropathy peripheral—Docetaxel—skin cancer	0.000504	0.00264	CcSEcCtD
Tenofovir—Pain—Bleomycin—skin cancer	0.0005	0.00262	CcSEcCtD
Tenofovir—Musculoskeletal discomfort—Dactinomycin—skin cancer	0.000497	0.00261	CcSEcCtD
Tenofovir—Nausea—Imiquimod—skin cancer	0.000489	0.00256	CcSEcCtD
Tenofovir—Hepatobiliary disease—Docetaxel—skin cancer	0.000487	0.00255	CcSEcCtD
Tenofovir—Nervous system disorder—Temozolomide—skin cancer	0.000484	0.00254	CcSEcCtD
Tenofovir—Skin disorder—Temozolomide—skin cancer	0.000479	0.00251	CcSEcCtD
Tenofovir—Hyperhidrosis—Temozolomide—skin cancer	0.000477	0.0025	CcSEcCtD
Tenofovir—Chest pain—Fluorouracil—skin cancer	0.000474	0.00249	CcSEcCtD
Tenofovir—Myalgia—Fluorouracil—skin cancer	0.000474	0.00249	CcSEcCtD
Tenofovir—Decreased appetite—Dactinomycin—skin cancer	0.000474	0.00249	CcSEcCtD
Tenofovir—Fatigue—Dactinomycin—skin cancer	0.00047	0.00247	CcSEcCtD
Tenofovir—Anorexia—Temozolomide—skin cancer	0.00047	0.00247	CcSEcCtD
Tenofovir—Pain—Dactinomycin—skin cancer	0.000467	0.00245	CcSEcCtD
Tenofovir—Body temperature increased—Bleomycin—skin cancer	0.000462	0.00243	CcSEcCtD
Tenofovir—Hepatitis—Docetaxel—skin cancer	0.000462	0.00242	CcSEcCtD
Tenofovir—Urinary tract disorder—Docetaxel—skin cancer	0.000456	0.00239	CcSEcCtD
Tenofovir—Connective tissue disorder—Docetaxel—skin cancer	0.000454	0.00238	CcSEcCtD
Tenofovir—Urethral disorder—Docetaxel—skin cancer	0.000453	0.00237	CcSEcCtD
Tenofovir—Musculoskeletal discomfort—Temozolomide—skin cancer	0.00045	0.00236	CcSEcCtD
Tenofovir—Insomnia—Temozolomide—skin cancer	0.000446	0.00234	CcSEcCtD
Tenofovir—Gastrointestinal pain—Dactinomycin—skin cancer	0.000446	0.00234	CcSEcCtD
Tenofovir—Nervous system disorder—Fluorouracil—skin cancer	0.000446	0.00234	CcSEcCtD
Tenofovir—Dyspnoea—Temozolomide—skin cancer	0.00044	0.00231	CcSEcCtD
Tenofovir—Dyspepsia—Temozolomide—skin cancer	0.000434	0.00228	CcSEcCtD
Tenofovir—Anorexia—Fluorouracil—skin cancer	0.000433	0.00227	CcSEcCtD
Tenofovir—Body temperature increased—Dactinomycin—skin cancer	0.000431	0.00226	CcSEcCtD
Tenofovir—Abdominal pain—Dactinomycin—skin cancer	0.000431	0.00226	CcSEcCtD
Tenofovir—Hypersensitivity—Bleomycin—skin cancer	0.000431	0.00226	CcSEcCtD
Tenofovir—Decreased appetite—Temozolomide—skin cancer	0.000429	0.00225	CcSEcCtD
Tenofovir—Gastrointestinal disorder—Temozolomide—skin cancer	0.000426	0.00223	CcSEcCtD
Tenofovir—Fatigue—Temozolomide—skin cancer	0.000425	0.00223	CcSEcCtD
Tenofovir—Pain—Temozolomide—skin cancer	0.000422	0.00221	CcSEcCtD
Tenofovir—Asthenia—Bleomycin—skin cancer	0.00042	0.0022	CcSEcCtD
Tenofovir—Immune system disorder—Docetaxel—skin cancer	0.000417	0.00219	CcSEcCtD
Tenofovir—Mediastinal disorder—Docetaxel—skin cancer	0.000416	0.00218	CcSEcCtD
Tenofovir—Musculoskeletal discomfort—Fluorouracil—skin cancer	0.000414	0.00217	CcSEcCtD
Tenofovir—Pruritus—Bleomycin—skin cancer	0.000414	0.00217	CcSEcCtD
Tenofovir—Insomnia—Fluorouracil—skin cancer	0.000411	0.00216	CcSEcCtD
Tenofovir—Dyspnoea—Fluorouracil—skin cancer	0.000405	0.00213	CcSEcCtD
Tenofovir—Mental disorder—Docetaxel—skin cancer	0.000405	0.00212	CcSEcCtD
Tenofovir—Gastrointestinal pain—Temozolomide—skin cancer	0.000404	0.00212	CcSEcCtD
Tenofovir—Malnutrition—Docetaxel—skin cancer	0.000402	0.00211	CcSEcCtD
Tenofovir—Hypersensitivity—Dactinomycin—skin cancer	0.000402	0.00211	CcSEcCtD
Tenofovir—Dyspepsia—Fluorouracil—skin cancer	0.0004	0.0021	CcSEcCtD
Tenofovir—Decreased appetite—Fluorouracil—skin cancer	0.000395	0.00207	CcSEcCtD
Tenofovir—Gastrointestinal disorder—Fluorouracil—skin cancer	0.000393	0.00206	CcSEcCtD
Tenofovir—Asthenia—Dactinomycin—skin cancer	0.000391	0.00205	CcSEcCtD
Tenofovir—Abdominal pain—Temozolomide—skin cancer	0.00039	0.00205	CcSEcCtD
Tenofovir—Body temperature increased—Temozolomide—skin cancer	0.00039	0.00205	CcSEcCtD
Tenofovir—Back pain—Docetaxel—skin cancer	0.000389	0.00204	CcSEcCtD
Tenofovir—Pain—Fluorouracil—skin cancer	0.000389	0.00204	CcSEcCtD
Tenofovir—Diarrhoea—Dactinomycin—skin cancer	0.000373	0.00196	CcSEcCtD
Tenofovir—Vomiting—Bleomycin—skin cancer	0.000372	0.00195	CcSEcCtD
Tenofovir—Rash—Bleomycin—skin cancer	0.000369	0.00193	CcSEcCtD
Tenofovir—Dermatitis—Bleomycin—skin cancer	0.000369	0.00193	CcSEcCtD
Tenofovir—Hypersensitivity—Temozolomide—skin cancer	0.000364	0.00191	CcSEcCtD
Tenofovir—Body temperature increased—Fluorouracil—skin cancer	0.000359	0.00188	CcSEcCtD
Tenofovir—Asthenia—Temozolomide—skin cancer	0.000354	0.00186	CcSEcCtD
Tenofovir—Pruritus—Temozolomide—skin cancer	0.000349	0.00183	CcSEcCtD
Tenofovir—Nausea—Bleomycin—skin cancer	0.000347	0.00182	CcSEcCtD
Tenofovir—Vomiting—Dactinomycin—skin cancer	0.000347	0.00182	CcSEcCtD
Tenofovir—Rash—Dactinomycin—skin cancer	0.000344	0.0018	CcSEcCtD
Tenofovir—Arthralgia—Docetaxel—skin cancer	0.000342	0.0018	CcSEcCtD
Tenofovir—Chest pain—Docetaxel—skin cancer	0.000342	0.0018	CcSEcCtD
Tenofovir—Myalgia—Docetaxel—skin cancer	0.000342	0.0018	CcSEcCtD
Tenofovir—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—skin cancer	0.00034	0.00178	CcSEcCtD
Tenofovir—Diarrhoea—Temozolomide—skin cancer	0.000338	0.00177	CcSEcCtD
Tenofovir—Hypersensitivity—Fluorouracil—skin cancer	0.000335	0.00176	CcSEcCtD
Tenofovir—Dizziness—Temozolomide—skin cancer	0.000326	0.00171	CcSEcCtD
Tenofovir—Nausea—Dactinomycin—skin cancer	0.000324	0.0017	CcSEcCtD
Tenofovir—Nervous system disorder—Docetaxel—skin cancer	0.000322	0.00169	CcSEcCtD
Tenofovir—Pruritus—Fluorouracil—skin cancer	0.000322	0.00169	CcSEcCtD
Tenofovir—Skin disorder—Docetaxel—skin cancer	0.000319	0.00167	CcSEcCtD
Tenofovir—Vomiting—Temozolomide—skin cancer	0.000314	0.00165	CcSEcCtD
Tenofovir—Anorexia—Docetaxel—skin cancer	0.000313	0.00164	CcSEcCtD
Tenofovir—Rash—Temozolomide—skin cancer	0.000311	0.00163	CcSEcCtD
Tenofovir—Diarrhoea—Fluorouracil—skin cancer	0.000311	0.00163	CcSEcCtD
Tenofovir—Dermatitis—Temozolomide—skin cancer	0.000311	0.00163	CcSEcCtD
Tenofovir—Headache—Temozolomide—skin cancer	0.000309	0.00162	CcSEcCtD
Tenofovir—Dizziness—Fluorouracil—skin cancer	0.000301	0.00158	CcSEcCtD
Tenofovir—Musculoskeletal discomfort—Docetaxel—skin cancer	0.000299	0.00157	CcSEcCtD
Tenofovir—Insomnia—Docetaxel—skin cancer	0.000297	0.00156	CcSEcCtD
Tenofovir—Nausea—Temozolomide—skin cancer	0.000293	0.00154	CcSEcCtD
Tenofovir—Dyspnoea—Docetaxel—skin cancer	0.000293	0.00153	CcSEcCtD
Tenofovir—Vomiting—Fluorouracil—skin cancer	0.000289	0.00152	CcSEcCtD
Tenofovir—Dyspepsia—Docetaxel—skin cancer	0.000289	0.00151	CcSEcCtD
Tenofovir—Rash—Fluorouracil—skin cancer	0.000287	0.0015	CcSEcCtD
Tenofovir—Dermatitis—Fluorouracil—skin cancer	0.000286	0.0015	CcSEcCtD
Tenofovir—Decreased appetite—Docetaxel—skin cancer	0.000285	0.0015	CcSEcCtD
Tenofovir—Headache—Fluorouracil—skin cancer	0.000285	0.00149	CcSEcCtD
Tenofovir—Gastrointestinal disorder—Docetaxel—skin cancer	0.000283	0.00149	CcSEcCtD
Tenofovir—Fatigue—Docetaxel—skin cancer	0.000283	0.00148	CcSEcCtD
Tenofovir—Pain—Docetaxel—skin cancer	0.000281	0.00147	CcSEcCtD
Tenofovir—Nausea—Fluorouracil—skin cancer	0.00027	0.00142	CcSEcCtD
Tenofovir—Gastrointestinal pain—Docetaxel—skin cancer	0.000268	0.00141	CcSEcCtD
Tenofovir—Body temperature increased—Docetaxel—skin cancer	0.000259	0.00136	CcSEcCtD
Tenofovir—Abdominal pain—Docetaxel—skin cancer	0.000259	0.00136	CcSEcCtD
Tenofovir—Hypersensitivity—Docetaxel—skin cancer	0.000242	0.00127	CcSEcCtD
Tenofovir—Asthenia—Docetaxel—skin cancer	0.000235	0.00123	CcSEcCtD
Tenofovir—Pruritus—Docetaxel—skin cancer	0.000232	0.00122	CcSEcCtD
Tenofovir—Diarrhoea—Docetaxel—skin cancer	0.000225	0.00118	CcSEcCtD
Tenofovir—Dizziness—Docetaxel—skin cancer	0.000217	0.00114	CcSEcCtD
Tenofovir—Vomiting—Docetaxel—skin cancer	0.000209	0.00109	CcSEcCtD
Tenofovir—Rash—Docetaxel—skin cancer	0.000207	0.00109	CcSEcCtD
Tenofovir—Dermatitis—Docetaxel—skin cancer	0.000207	0.00108	CcSEcCtD
Tenofovir—Headache—Docetaxel—skin cancer	0.000206	0.00108	CcSEcCtD
Tenofovir—Nausea—Docetaxel—skin cancer	0.000195	0.00102	CcSEcCtD
